This move is archived. Current quotes and coverage live on the stock page.
Get APLI alerts:
Appili Therapeutics Inc is facing a significant downturn, raising concerns among investors.
Appili Therapeutics Inc (APLI.TO) stock has dropped 33.33% in today’s trading session, closing at just CA$0.01. This steep decline has left many investors questioning the future of the company as it struggles to maintain its market presence.
Investor takeaway: Keep an eye on Appili Therapeutics Inc for any signs of recovery or further decline, as the stock's current performance raises concerns about its viability.
Advertisement
Appili Therapeutics Inc
APLI.TO
APLI.TO
Appili Therapeutics Inc
WealthAwesomeMarket cap
$1.99M
52W high
$0.04
52W low
$0.01
1W change
+50.00%
Beta
-0.20
Analyst Price Targets
Based on analyst covering APLI
Wall Street analysts forecast APLI stock price to rise 900.0% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$0.15
+900.0% Upside
Current Price
C$0.01
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on APLI's historical volatility
30-Day Vol
292.8%
Annualized
90-Day Vol
261.7%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$0.01
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.01 | C$0.01 – C$0.04 |
| 60 trading days | C$0.01 | C$0.00 – C$0.06 |
| 90 trading days | C$0.01 | C$0.00 – C$0.07 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Stock Down 33.33% Today
With a market cap of just CA$1.98 million, Appili Therapeutics Inc is in a tough spot following today's drastic drop.
Bull case
If Appili Therapeutics can change its strategy or secure new funding, there may be a chance for recovery in the future.
Bear case
Ongoing losses could further erode investor confidence and lead to potential delisting from the exchange, especially given its low market cap of CA$1,985,491.
Advertisement
Understanding the Decline
The 33.33% drop in Appili Therapeutics Inc's stock price today has raised alarms among investors. With no recent news or announcements from the company, the reasons behind this sharp decline remain unclear. Investors are left to wonder whether this is a reaction to broader market trends or specific issues within the company itself.
Market Implications
With a market cap of only CA$1.98 million, Appili Therapeutics Inc is now in a precarious position. The significant drop in stock price could hinder its ability to attract new investments or partnerships, which are crucial for its survival. Investors should be cautious as the stock's future appears uncertain.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
